Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Bristol-Myers Squibb will pay $350 million to settle Hawaii's lawsuit over Plavix marketing practices, ending claims without ...

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

HPR's Ashley Mizuo reports on the settlement between two pharmaceutical companies, Sanofi and Bristol Myers Squibb in the ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

Pharmaceutical giants Bristol Myers Squibb and Sanofi have agreed to pay $700 million to Hawaii to settle a lawsuit over the efficacy and labeling of the blood thinner Plavix ...

and three units of Sanofi (NASDAQ:SNY) have agreed to pay $700M to the state to resolve nearly 12 years of litigation related to the companies’ marketing of blood thinner Plavix. The lawsuit ...

Hawaii will receive a $700 million settlement from pharmaceutical companies Bristol Myers Squibb and Sanofi over the blood ...